Zydus cleared to begin US trial of oral therapy usnoflast for ALS
Zydus Lifesciences has been cleared by the U.S. Food and Drug Administration (FDA) to initiate a Phase 2b trial…
Articles by Katherine Poinsatte, PhD
$20M gift to Florida university supports ALS research, care
Note: This story was updated July 24, 2025, to correct the name of Nova Southeastern University. A Chicago businessman and…
Neurosense plans to license rights to advance PrimeC in certain regions
Neurosense Therapeutics has entered a binding term sheet with a leading global pharmaceutical company to advance the development and…
Specialists twice as fast as general neurologists at diagnosing ALS
Specialists diagnose amyotrophic lateral sclerosis (ALS) twice as fast as general neurologists, research…
ALS Association funds small clinical trial of intranasal foralumab in ALS
The ALS Association has awarded a “groundbreaking” grant to Tiziana Life Sciences to support a small, early-stage clinical…
Research grant provides $7.3M for NU-9 development
Researchers at Northwestern University received a $7.3 million research grant from the National Institute on Aging to expand their work…
Vitamin B12 treatment Rozebalamin approved for ALS in Japan
An ultra-high dose of mecobalamin, a naturally occurring form of vitamin B12, has been approved in Japan under the brand…
Neuvivo requests FDA approval of ALS treatment NP001
Neuvivo has filed an application with the U.S. Food and Drug Administration (FDA) requesting the approval of its investigational…
Initiative aims to improve ALS research, clinical trial access
Two amyotrophic lateral sclerosis (ALS) centers are backing an initiative aimed at accelerating and improving ALS research. The Acceleration…
ALS diagnosis takes longer for Black patients than white patients: Study
Black people with amyotrophic lateral sclerosis (ALS) tend to have a different disease course than white patients; they are…